NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Active Profile

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Biofortuna Extends its Exclusive Distribution Agreement with Abbott to Cover All Global Territories - Biofortuna Ltd, a UK-based molecular diagnostics company, have extended its exclusive distribution agreement with Abbott, for its SSPGo™ range of freeze dried HLA typing kits, to now include France, Spain, Portugal & the Benelux countries - Biofortuna.com
Biofortuna Extends its Exclusive Distribution Agreement with Abbott to Cover All Global Territories

 

NewswireTODAY - /newswire/ - Liverpool, Merseyside, United Kingdom, 2012/04/26 - Biofortuna Ltd, a UK-based molecular diagnostics company, have extended its exclusive distribution agreement with Abbott, for its SSPGo™ range of freeze dried HLA typing kits, to now include France, Spain, Portugal & the Benelux countries - Biofortuna.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Under terms of the agreement, first announced in April, 2011, Abbott now obtains exclusive rights to distribute the range of SSPGoTM products, Verdict interpretation software, as well as kit updates and improvements, in all global territories.

Biofortuna’s novel proprietary freeze-drying capabilities, allows PCR diagnostic kits to be stable at ambient temperature for up to 16 months, eliminating the requirement for refrigerators, freezers, and temperature-controlled shipping. Biofortuna is now offering this proprietary manufacturing expertise as a contract service to diagnostic companies. As all reagents for PCR are freeze dried, the end user is only required to add patient DNA prior to amplification and detection. Biofortuna’s freeze dried kits offer significant cost and time savings to laboratories by reducing labour, consumables, and the potential for errors.

Dr Mike Bunce, CSO of Biofortuna said: “We are delighted that Abbott has become a global exclusive distributor of our SSPGoTM range of kits. Success of this product in EMEAI and Asia Pacific markets is a clear indication of the growing demand of our proprietary freeze dried kits and Abbott’s ability to market and support this product.’’

About Biofortuna Ltd

Biofortuna Ltd (biofortuna.com), the UK-based molecular diagnostics company, specialises in proprietary freeze-dried HLA diagnostics. Biofortuna has a number of freeze-dried molecular diagnostic products targeted at the transplantation market. It is also developing a portfolio of additional tests with the aim of providing easy-to-use diagnostics that address complex genotyping issues, whilst increasing laboratory productivity and improving quality in clinical testing and patient care.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Active Profile

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Biofortuna Extends its Exclusive Distribution Agreement with Abbott to Cover All Global Territories

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Claire Gallagher - ActiveProfile.co.uk 
+44(0)15 1705 3675 info[.]biofortuna.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Active Profile securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Active Profile / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

BAE Systems to Develop AI-powered Software to Improve Battlefield Medical Care for Warfighters
SCHOTT Pharma and SHL Medical Enhance Home-based Large-volume Injections for Patients
Bruker MALDI Biotyper® Sirius and Sirius One Systems Awarded ACT Label for Environmental Accountability
Datalogic and B. Braun Enable Safer Oncology Treatment with Memor 17 Healthcare Certification for OncoSafety Remote Control
Withings Launches Withings Intelligence in Beta - AI-Driven Insights to Decode your Health
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis
Bruker Unveils New ProteoElute™ NanoLC System and PepSep® Advanced NLC Columns for up to 50% Improved Peptide Sensitivity
Kraiburg-TPE Introduces Next-level Performance in Medical Tubing with THERMOLAST® H
Ambiq and CardioMedive Deliver ​Unified​ Medical ​Cardiac ​Care Solution
Imec Presents Prototype of Ingestible Sensor for Gut Health Monitoring
SCHOTT Pharma Unveils Polymer Syringe for Ultra-low Temperature Storage At -180 °C
Bruker Announces Successful Acceptance of 1.2 GHz NMR Spectrometer At University of Warwick
Toshiba Receives Order for Heavy Ion Therapy System from Asan Medical Center in South Korea
Philips Applauded by Frost & Sullivan for Improving Imaging Quality and Efficiency in Healthcare with its CT 3500 Imaging Solution
Withings Announces the Availability of Revolutionary Thermometer BeamO

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2005-2025 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)